Using our mobile app? Be sure to check for any new app updates to receive any enhancements.
Logo

Manténgase sano!

Resultados de su búsqueda "Nose Bleeds".

Resultados de noticias de salud - 1

More than half of people with a rare life-threatening bleeding condition received lasting relief from an experimental antibody treatment, clinical trial results show.

Ianalumab, a monoclonal antibody, helped patients with immune thrombocytopenia (ITP) maintain safe platelet counts without serious bleeding episodes for at least a year, according to results published Dec. 9 in

  • Dennis Thompson HealthDay Reporter
  • |
  • December 12, 2025
  • |
  • Página completa